| P50 | author | Timothy Ming-Hun Wan | Q114575707 |
| | T Yau | Q56997342 |
| | Chi Chung Foo | Q57105527 |
| | Lui Ng | Q59690622 |
| | Wai Keung Leung | Q70876398 |
| | Deepak Iyer | Q87823109 |
| | Guanghua Chen | Q87823111 |
| | Jensen Tung-Chung Poon | Q114575698 |
| | Roberta W C Pang | Q114575700 |
| | Ariel Ka-Man Chow | Q114575702 |
| | Johnny Hon-Wai Man | Q114575704 |
| | Oswens Siu-Hung Lo | Q114575705 |
| P2093 | author name string | Wai-Lun Law | |
| P2860 | cites work | Serum microRNAs are promising novel biomarkers | Q21144238 |
| | Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 |
| | Colorectal Cancer Biomarkers: Where Are We Now? | Q27003134 |
| | MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 |
| | Decreased levels of miR-224 and the passenger strand of miR-221 increase MBD2, suppressing maspin and promoting colorectal tumor growth and metastasis in mice | Q28118790 |
| | Biomarkers: Portents of malignancy | Q28307861 |
| | Comparing the MicroRNA spectrum between serum and plasma | Q31080442 |
| | A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer | Q33742015 |
| | Global patterns of cancer incidence and mortality rates and trends | Q34127168 |
| | MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas. | Q34136208 |
| | Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours | Q34176288 |
| | Circulating microRNAs as specific biomarkers for breast cancer detection. | Q34542335 |
| | A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells | Q34587506 |
| | MicroRNA-139-3p indicates a poor prognosis of colon cancer | Q34733024 |
| | Colorectal cancers with microsatellite instability display unique miRNA profiles. | Q35269096 |
| | Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection | Q35929207 |
| | The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis | Q36090214 |
| | microRNA expression pattern and its alteration following celecoxib intervention in human colorectal cancer | Q36224336 |
| | CEA monitoring in colorectal cancer. What you should know. | Q36506544 |
| | Blood markers for early detection of colorectal cancer: a systematic review | Q36968878 |
| | MicroRNA-21 as a potential colon and rectal cancer biomarker | Q37162427 |
| | Systematic review with meta-analysis: faecal occult blood tests show lower colorectal cancer detection rates in the proximal colon in colonoscopy-verified diagnostic studies. | Q38726927 |
| | MicroRNA-139 suppresses proliferation in luminal type breast cancer cells by targeting Topoisomerase II alpha | Q38863517 |
| | miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2. | Q38869864 |
| | MiR-622 inhibited colorectal cancer occurrence and metastasis by suppressing K-Ras | Q40581387 |
| | A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer. | Q43686660 |
| | How to explain the contradiction of microRNA 200c expression and survival in solid tumors? A meta-analysis | Q44829356 |
| | Sample size calculation should be performed for design accuracy in diagnostic test studies | Q47375214 |
| | MicroRNA expression profiles in human colorectal cancers with liver metastases | Q95423102 |
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| | colorectal cancer | Q188874 |
| P304 | page(s) | 27393-27400 | |
| P577 | publication date | 2017-04-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer | |
| P478 | volume | 8 | |